Unknown

Dataset Information

0

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.


ABSTRACT: Hepatocellular carcinoma (HCC) is the fastest-rising cause of cancer-related death in the United States. Recent epidemiological studies have identified nonalcoholic steatohepatitis (NASH), a progressive form of nonalcoholic fatty liver disease (NAFLD), as a major risk factor for HCC. Elucidating the underlying mechanisms associated with the development of NASH-derived HCC is critical for identifying early biomarkers for the progression of the disease and for treatment and prevention. In the present study, using liver samples from C57BL/6J mice submitted to the Stelic Animal Model (STAM) of NASH-associated liver carcinogenesis, we investigated the role of microRNA (miRNA) alterations in the pathogenesis of NASH-derived HCC. We found substantial alterations in the expression of miRNAs, with the greatest number occurring in full-fledged HCC. Mechanistically, altered miRNA expression was associated with activation of major hepatocarcinogenesis-related pathways, including the TGF-?, Wnt/?-catenin, ERK1/2, mTOR, and EGF signaling. In addition, the over-expression of the miR-221-3p and miR-222-3p and oncogenic miR-106b?25 cluster was accompanied by the reduced protein levels of their targets, including E2F transcription factor 1 (E2F1), phosphatase and tensin homolog (PTEN), and cyclin-dependent kinase inhibitor 1 (CDKN1A). Importantly, miR-93-5p, miR-221-3p, and miR-222-3p were also significantly over-expressed in human HCC. These findings suggest that aberrant expression of miRNAs may have mechanistic significance in NASH-associated liver carcinogenesis and may serve as an indicator for the development of NASH-derived HCC.

SUBMITTER: de Conti A 

PROVIDER: S-EPMC5687623 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.

de Conti Aline A   Ortega Juliana Festa JF   Tryndyak Volodymyr V   Dreval Kostiantyn K   Moreno Fernando Salvador FS   Rusyn Ivan I   Beland Frederick A FA   Pogribny Igor P IP  

Oncotarget 20170801 51


Hepatocellular carcinoma (HCC) is the fastest-rising cause of cancer-related death in the United States. Recent epidemiological studies have identified nonalcoholic steatohepatitis (NASH), a progressive form of nonalcoholic fatty liver disease (NAFLD), as a major risk factor for HCC. Elucidating the underlying mechanisms associated with the development of NASH-derived HCC is critical for identifying early biomarkers for the progression of the disease and for treatment and prevention. In the pres  ...[more]

Similar Datasets

| S-EPMC9151706 | biostudies-literature
| S-EPMC2717729 | biostudies-literature
| S-EPMC9846941 | biostudies-literature
| S-EPMC5341981 | biostudies-literature
| S-EPMC4491606 | biostudies-literature
| S-EPMC3378283 | biostudies-literature
| S-EPMC6549534 | biostudies-literature
| S-EPMC6928943 | biostudies-literature
| S-EPMC6589210 | biostudies-literature